Congenital hyperinsulinism: recent updates on molecular mechanisms, diagnosis and management
- 21 September 2021
- journal article
- review article
- Published by Walter de Gruyter GmbH in Journal of Pediatric Endocrinology and Metabolism
- Vol. 35 (3) , 279-296
Abstract
Congenital hyperinsulinism (CHI) is a rare disease characterized by an unregulated insulin release, leading to hypoglycaemia. It is the most frequent cause of persistent and severe hypoglycaemia in the neonatal period and early childhood. Mutations in 16 different key genes ( ABCC8 , KCNJ11 , GLUD1 , GCK , HADH , SLC16A1 , UCP2 , HNF4A , HNF1A , HK1 , KCNQ1 , CACNA1D , FOXA2 , EIF2S3 , PGM1 and PMM2 ) that are involved in regulating the insulin secretion from pancreatic β-cells have been described to be responsible for the underlying molecular mechanisms of CHI. CHI can also be associated with specific syndromes and can be secondary to intrauterine growth restriction (IUGR), maternal diabetes, birth asphyxia, etc. It is important to diagnose and promptly initiate appropriate management as untreated hypoglycaemia can be associated with significant neurodisability. CHI can be histopathologically classified into diffuse, focal and atypical forms. Advances in molecular genetics, imaging techniques (18F-fluoro- l -dihydroxyphenylalanine positron emission tomography/computed tomography scanning), novel medical therapies and surgical advances (laparoscopic pancreatectomy) have changed the management and improved the outcome of patients with CHI. This review article provides an overview of the background, clinical presentation, diagnosis, molecular genetics and therapy for children with different forms of CHI.Keywords
This publication has 145 references indexed in Scilit:
- Abnormal Neurodevelopmental Outcomes are Common in Children with Transient Congenital HyperinsulinismFrontiers in Endocrinology, 2013
- The Value of Radiologic Interventions and 18F-DOPA PET in Diagnosing and Localizing Focal Congenital Hyperinsulinism: Systematic Review and Meta-AnalysisMolecular Imaging and Biology, 2012
- Pancreatic head resection and Roux-en-Y pancreaticojejunostomy for the treatment of the focal form of congenital hyperinsulinismJournal of Pediatric Surgery, 2012
- Rapamycin induces glucose intolerance in mice by reducing islet mass, insulin content, and insulin sensitivityJournal of Molecular Medicine, 2011
- Hyperinsulinaemic hypoglycaemia and diabetes mellitus due to dominant ABCC8/KCNJ11 mutationsDiabetologia, 2011
- Dominantly acting ABCC8 mutations in patients with medically unresponsive hyperinsulinaemic hypoglycaemiaClinical Genetics, 2011
- Dynamic regulation of Pdx1 enhancers by Foxa1 and Foxa2 is essential for pancreas developmentGenes & Development, 2008
- Exendin-(9–39) Corrects Fasting Hypoglycemia in SUR-1–/– Mice by Lowering cAMP in Pancreatic β-Cells and Inhibiting Insulin SecretionJournal of Biological Chemistry, 2008
- Physical Exercise–Induced Hypoglycemia Caused by Failed Silencing of Monocarboxylate Transporter 1 in Pancreatic β CellsThe American Journal of Human Genetics, 2007
- Prolonged hyperinsulinaemic hypoglycaemia in newborns with intrauterine growth retardationArchives of Disease in Childhood - Fetal and Neonatal Edition, 2006